Fang-Tzu Hsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fang-Tzu Hsu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Han Yu Lee
Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan
1 shared publication- Pei Yuin Keng
National Tsing Hua University
1 shared publication Shi-Chih Huang
Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan
1 shared publication- Tzu-Wei Wang
National Tsing Hua University
1 shared publication Wan Yun Fu
Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan
1 shared publicationWei-Yuan Huang
Department of Material Science and Engineering, National Tsing Hua University, Hsinchu City 300, Taiwan
1 shared publication
Latest Publications
- Open Access
- 7 June 2024
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (7) , 4215-4232
Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies
Boron neutron capture therapy (BNCT) targets invasive, radioresistant cancers but requires a selective and high B-10 loading boron drug. This manuscript investigates boron-rich poly(ethylene glycol)-block-(poly(4-vinylphenyl boronate ester)) polymer micelles synthesized via atom transfer radical polymerization for their potential application in BNCT. Transmission electron microscopy (TEM) revealed spherical micelles with a uniform size of 43 ± 10 nm, ideal for drug delivery. Additionally, probe sonication proved effective in maintaining the micelles' size and morphology postlyophilization and reconstitution. In vitro studies with B16-F10 melanoma cells demonstrated a 38-fold increase in boron accumulation compared to the borophenylalanine drug for BNCT. In vivo studies in a B16-F10 tumor-bearing mouse model confirmed enhanced tumor selectivity and accumulation, with a tumor-to-blood (T/B) ratio of 2.5, surpassing BPA's T/B ratio of 1.8. As a result, mice treated with these micelles experienced a significant delay in tumor growth, highlighting their potential for BNCT and warranting further research.
- 7 June 2024
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 25 (7) , 4215-4232
Open AccessBoron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies
Boron neutron capture therapy (BNCT) targets invasive, radioresistant cancers but requires a selective and high B-10 loading boron drug. This manuscript investigates boron-rich poly(ethylene glycol)-block-(poly(4-vinylphenyl boronate ester)) polymer micelles synthesized via atom transfer radical polymerization for their potential application in BNCT. Transmission electron microscopy (TEM) revealed spherical micelles with a uniform size of 43 ± 10 nm, ideal for drug delivery. Additionally, probe sonication proved effective in maintaining the micelles' size and morphology postlyophilization and reconstitution. In vitro studies with B16-F10 melanoma cells demonstrated a 38-fold increase in boron accumulation compared to the borophenylalanine drug for BNCT. In vivo studies in a B16-F10 tumor-bearing mouse model confirmed enhanced tumor selectivity and accumulation, with a tumor-to-blood (T/B) ratio of 2.5, surpassing BPA's T/B ratio of 1.8. As a result, mice treated with these micelles experienced a significant delay in tumor growth, highlighting their potential for BNCT and warranting further research.